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ABSTRACT
Since it is unknown whether thyroid hormones (THs) regulate mitochondrial function in human epidermis, we treated organ-cultured human skin with triiodothyronine (T 3, 100 pM) or thyroxine (T 4, 100 nM). Both THs significantly increased protein expression of the mitochondrially-encoded cytochrome C oxidase I (MTCO1), complex I activity, and the number of perinuclear mitochondria. T 3 also increased mitochondrial transcription factor A (TFAM) protein expression, while T 4 stimulated complex II/IV activity. Increased mitochondrial function can correlate with increased reactive oxygen species (ROS) production, DNA damage and accelerated tissue aging. However, in isolated cultured human epidermal keratinocytes, THs neither raised ROS production nor matrix metalloproteinase (MMP)-1, -2 and -9 activity, nor decreased Sirt1 immunoreactivity. Instead, T 3 increased sirtuin-1, fibrillin-1, proliferator-activated receptor-gamma 1-alpha (PGC1α), collagen I and III transcription, while T 4 decreased p16 ink4 expression in organ-cultured human skin. Moreover, TH treatment increased intracutaneous fibrillin-rich microfibril and collagen III deposition and decreased mammalian target of rapamycin (mTORC1/2) expression ex vivo. This identifies THs as potent endocrine stimulators of mitochondrial function in human epidermis, which down-regulate, rather than enhance, the expression of skin aging-related biomarkers ex vivo. Therefore, topically applied THs deserve further exploration as candidate agents for treating skin conditions characterized by reduced mitochondrial function.
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INTRODUCTION
Thyroxine (T 4 ) and triiodothyronine (T 3 ) are amino acid derivate hormones synthesized and secreted by the thyroid gland. They operate as key regulators of human energy metabolism and stimulate mitochondrial activity and biogenesis in many different organs (Cioffi et al., 2013; Johannsen et al., 2012; Norman and Henry, 2015; Weitzel et al., 2003; Yehuda-Shnaidman et al., 2014 ). Yet, although mammalian skin is a prominent target organ of thyroid hormones (THs) in health and disease (Antonini et al., 2013; Contreras-Jurado et al., 2011; Ramot et al., 2009; Safer, 2012; van Beek et al., 2008) , it remains unknown whether and how THs impact on mitochondrial function in human epidermis.
Since TH can stimulate mitochondrial energy metabolism in human scalp hair follicle, the main aim of our study was to clarify whether mitochondrial activity is also stimulated by THs in human epidermal keratinocytes in situ, i.e. in organ-cultured human skin under serum-and TH-free conditions.
First, we investigated the expression of mitochondrially encoded cytochrome c oxidase I (MTCO1), the mitochondrial transcription factor A (TFAM), which controls mitochondrial biogenesis and mitochondrial DNA synthesis (Baris et al., 2011; Campbell et al., 2012; Kloepper et al., 2015; Shutt et al., 2011) , and the peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α), a key transcription factor that regulates mitochondrial biogenesis and numerous other cell functions including aging, whose reduction in activity has an aging-promoting effect (Dabrowska et al., 2015; Gilbert, 2013; Riera and Dillin, 2015) . To assess whether any expression changes in these parameters altered also the intraepidermal mitochondrial oxidative phosphorylation, we asked whether THs modified the activity of complex I, the initial step of the mitochondrial respiratory chain (Chandel and Jeffs, 2015; Hirst, 2013; Scheffler, 2008) . Finally, since THs stimulate mitochondrial biogenesis in several human cell types ( Cioffi et al., 2013; Lee et al., 2012; Marin-Garcia, 2010) and human hair follicles (Vidali et al., 2014) , we asked by transmission electron microscopy whether this also occurred in human epidermis ex vivo.
Increased mitochondrial activity may exert both beneficial and deleterious effects; the latter include the promotion of aging-associated pathways by enhancing ROS production and subsequent DNA damage (Bratic and Larsson, 2013; Kozieł et al., 2011; Swerdlow, 2016) . Therefore, a secondary aim of our study was to explore whether THs promote the expression of oxidative-stress and/or skin agingrelated biomarkers routinely used in human skin aging research (Berneburg, 2008; Gilchrest, 2013; Jeong et al., 2015; Langton et al., 2012; Yoon et al., 2014) .
For this purpose, matrix-metalloproteinases (MMPs) -1 (collagenase), -2 and -9 (gelatinases-A and -B), were investigated since these are typically up-regulated in aged skin where they degrade dermal collagens, elastic fibers and fibrillin-rich microfibrils (Ashworth et al., 1999; Kim et al., 2010; , 2010; Veidal et al., 2010) . The major structural component of fibrillin-rich microfibrils, fibrillin-1, was also analysed, since it is a sensitive indicator of intrinsic and extrinsic skin aging (Naylor et al., 2011; Watson et al., 1999; 2008; 2014) , along with mature collagen type I and III, since their expression decreases progressively during skin aging (Attia-Vigneau et al., 2014; Baroni Edo et al., 2012; Berneburg, 2008; Gilchrest, 2013; Langton et al., 2012) .
Moreover. we investigated the effect of THs on the transcription of sirtuin-1 (sirt1), which is associated with lifespan expansion in common laboratory species, regulates senescence, aging, genomic stability and mitochondrial homeostasis (Fang et al., 2016; Hayakawa et al., 2015; Poulose and Raju, 2015) , and the sirt1 target, PGC1α, a central regulator of aging, which enhances mitochondrial biogenesis and controls oxidative stress by up-regulating important ROS scavengers (Austin and St-Pierre, 2012; Gilbert, 2013; Riera and Dillin, 2015; Wenz, 2011) . Finally, we quantified the cyclin-dependent kinase inhibitor 2A, multiple tumor suppressor 1 (p16 ink4a ), a key cell cycle senescence biomarker (Baker et al., 2011) and the mammalian target of rapamycin (mTORC1/2), another key regulator of ageing (Chiao et al., 2016; Evangelisti et al., 2016; Johnson et al., 2013) .
Taken together, these experiments identify THs as potent endocrine stimulators of mitochondrial function in human epidermis, which down-regulate, rather than enhance, the expression of skin agingrelated biomarkers ex vivo. 
RESULTS
THs enhance intraepidermal oxidative phosphorylation activity
Nitro blue tetrazolium (NBT) reduction assay ( Knuever et al., 2012; Poeggeler et al., 2010) showed that T 3 and T 4 significantly enhanced complex I activity in human epidermis ex vivo (Figure 1m Since actual ATP production in human epidermis in situ could not be measured, we investigated ATP production in cultured human primary epidermal keratinocytes. However, neither T 3 nor T 4 treatment significantly altered ATP formation in our experimental system (Supplementary Figure S2) .
Therefore, it remains to be determined whether TH stimulation impacts on intraepidermal ATP synthesis.
T 3 and T 4 treatment increases the number of mitochondria
By transmission electron microscopy, we found that T 3 and T 4 significantly increased the number of ultrastructurally detectable mitochondria in the perinuclear area of individually examined human epidermal keratinocytes in situ by 30% and 33%, respectively (Supplementary Figure S3 ). Although we cannot exclude that THs only shifted the intracellular position of mitochondria to a perinuclear location, our data, together with the increased TFAM and MTCO1 expression, suggest that THs might stimulate mitochondrial biogenesis in healthy human epidermis.
THs modulate intraepidermal expression of standard aging-related read out parameters in human skin
Quantitative immunohistomorphometry showed that both THs significantly down-regulated MMP-1 IR ( Figure 2a -h) after 24 hours, but not after 6 days. As antibody-based methods identify both the proand active forms of these enzymes, intraepidermal MMP-1 activity (Figure 2i-p) was also investigated by in situ zymography. This showed that MMP-1 activity remained unaffected after both 24 hours and 6 days of TH treatment. Furthermore, we found that T 3 significantly decreased the intracutaneous activity of MMP-2 and -9 after 6 days ex vivo (Figure 3a -h).
Quantitative immunohistomorphometry for mature collagen type III revealed that its IR was strongly up-regulated after 6 days of treatment with T 3 (Figure 3i Interestingly, T 4 decreased the mRNA levels of collagen I and III, fibrillin 1, sirt1 and PGC1α, but this did not affect the protein expression, as shown by the immunoreactivity results.
THs do not up-regulate ROS production in human epidermal keratinocytes
Finally, we probed whether TH-stimulated keratinocyte mitochondrial activity is associated with increased ROS production. As the latter is difficult to assess in tissue sections, this was examined in cultured primary human epidermal keratinocytes (NHEK), using a ROS-specific dye (CM-H2DCFDA) (Vidali et al., 2014) . This showed that treatment with different concentrations of either T 3
(50, 100 and 200 pM) or T 4 (50, 100 and 200 nM) for 24 hours failed to increase ROS production (Supplementary Figure S6) .
DISCUSSION
Here, we present, that physiological concentrations of exogenous THs (Molina and Ashman, 2010; van Beek et al., 2008) up-regulate mitochondrial function and the number of mitochondria in normal human epidermis in serum-and TH-free skin organ culture (see Supplementary Table 1 for an overview of the results). As declining mitochondrial function and energy metabolism are characteristics of aged and aging tissues, the restoration of mitochondrial bioenergetics has been advocated as an effective approach for the treatment of numerous aging-associated pathologies (Fang et al., 2016; Poulose and Raju, 2015; Szeto, 2014; Wallace, 2011; Wallace et al., 2010) . Moreover, increasing evidence suggests that numerous skin diseases are linked to mitochondrial dysfunction and that restoration of mitochondrial function may offer an attractive auxiliary therapy for managing these skin disorders (Boulton et al., 2015; Feichtinger et al., 2014) . Therefore, promoting mitochondrial function in human skin, in theory, may also exert anti-aging properties.
However, a pragmatic and effective pharmacological strategy for achieving this in human skin remains to be developed. The current study suggests that T 4 , an inexpensive, toxicologically very well-defined hormone that has been systemically administered in clinical medicine for decades (Biondi and Wartofsky, 2014; Topliss and Soh, 2013) and is intracutaneously deiodinated to T 3 (van Beek et al., 2008) , could serve in the treatment of skin conditions and pathologies connected with a decline in mitochondrial function (Boulton et al., 2015) , intrinsic and extrinsic skin aging (Anderson et al., 2014;  M A N U S C R I P T
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7 Berneburg, 2008; Gilchrest, 2013; Glass et al., 2013; Grillon et al., 2012; Kaneko et al., 2012; Oyewole et al., 2014) . Topical application of T 4 is expected to reduce the well-known adverse effects associated with elevated systemic TH levels (Kharlip and Cooper, 2009; Taylor et al., 2013; Walrand et al., 2014) . Interestingly, topical T 3 has already been shown to promote murine skin wound healing and hair growth in vivo (Safer, 2012; Safer et al., 2005) , while a topically applied TH analogue counteracted glucocorticoid-induced human skin atrophy (Yazdanparast et al., 2006 ).
Whilst the current study was not designed to prove or disprove anti-aging effects of THs in human skin, which requires additional systematic research and longer-term analyses, we aimed to probe whether THs also promote undesired collateral effects associated with increased mitochondrial ROS production which could potentially promote tissue damage and skin aging. While the data reported
herein cannot yet conclusively rule out this possibility, they render this possibility unlikely. Instead, our current data suggest that THs rather exhibit anti-aging properties in human skin ex vivo, at least during the relatively short experimental window investigated here.
Firstly, MMP-1 protein expression and MMPs-2/-9 activity are both up-regulated in aged skin (Geng et al., 2010; Kim et al., 2010; Sherratt et al., 2010 ), yet are down-regulated by T 3 or T 4 treatment (Figure 2 and 3) . Secondly, deposition of fibrillin-1 protein is enhanced by THs, along with a marked improvement in the overall structure of fibrillin-rich microfibrils in the papillary dermis (Supplementary Figure S4) , similar to the effects reported for other candidate human skin anti-aging agents (Watson et al., 2001; 2008; 2014) . Thirdly, T 4 down-regulated the senescence marker p16 ink4 , while T 3 up-regulated the gene expression of both, sirt1 and PGC1α on the mRNA and protein level, two key regulators of cellular oxidative stress, aging and mitochondrial function (Austin and StPierre, 2012; Baker et al., 2011; Dabrowska et al., 2015; Geng et al., 2010) .
The mitochondrial data here presented suggest that THs stimulate intraepidermal mitochondrial biogenesis (Supplementary Figure S3) as they do in many other tissues, including human hair follicles (Cioffi et al., 2013; Lee et al., 2012; Marin-Garcia, 2010; Santillo et al., 2013; Vakitus et al., 2015; Vidali et al., 2014) , via a sirt1-PGC1α-mediated pathway. Also, both THs decreased mTORC1/2, whose inhibition is involved in mitochondrial biogenesis and reportedly restores a more juvenile phenotype and increased life span (Chiao et al., 2016; Evangelisti et al., 2016; Johnson et al., 2013) .
Finally, THs did not increase ROS production, at least in cultured primary human keratinocytes. Of course, this system cannot predict how long-term administration of THs might eventually upset the balance between beneficial and detrimental properties of these hormones with respect to intracutaneous oxidative stress.
Unexpectedly, 24 hours of treatment with T 4 decreased the mRNA levels of collagen I and III, fibrillin 1, sirt1 and PGC1α, in contrast with the protein expression data, where T 4 did not change their immunoreactivity after 24 hours and, for sirt1, collagen I and III, also after 6 days. This suggests that,
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8 as first response to T 4 treatment, the cells might down regulate the mRNA levels of these parameters, but their expression will then stabilize at the same level of the untreated skin in the longer run.
However, to have a better view on how T 4 acts on a genomic level it would be necessary to investigate the mRNA expression at different time points, but due to the scare amount of available human skin, this was not possible.
Another interesting point is that since T 3 is the active form of T 4 , one would expect that T 3 is indeed more active than T 4 . Here, this was not always the case in line with previous observations for the response of human hair follicles to T 3 versus T 4 (van Beek et al., 2008) . This might relate to the finding that T 4 can also act directly through distinct pathways that do not require prior conversion to T 3 (Cheng et al., 2010; Davis et al., 2016; Oyanagi et al., 2015) . Given that we only examined skin from middle-aged/older women in order to circumvent confounding gender influences, it will be interesting to study, next, whether mitochondrial activity-promoting and/or skin aging inhibitory effects of THs are also seen in male skin (unfortunately, much less male skin is available from cosmetic surgery, making this considerably more difficult to study).
Since THs induce a plethora of gene expression changes and functional effects through genomic and non-genomic pathways (Chen et al., 2013; Davis et al., 2016; Iordanidou et al., 2010; Senese et al., 2014) , it will be a major challenge to dissect the exact mechanisms by which THs impact on keratinocyte mitochondrial biology and human skin aging. However, given that genomic TH actions are mediated by TH nuclear receptors, c-erb Aα and Aβ (Tata, 2013; Verga Falzacappa et al., 2009; Weitzel and Iwen, 2011) , it is relevant that human keratinocytes express both TH nuclear receptors (Billoni et al., 2000; Contreras-Jurado et al., 2011) . Intriguingly, isoforms of the two receptors, like p43, have also been found in mitochondria ( Cioffi et al., 2013; Lin et al., 2011; Tata, 2013; Weitzel et al., 2003) . Thus, it is conceivable that these isoforms could mediate some direct, non-genomic effects of THs on human keratinocyte mitochondria.
Finally, some of the mechanisms and read-out parameters described here are shared between wound healing and aging. Therefore, one might wonder whether THs only exert pseudo-anti-aging effect by inhibiting wound healing in our ex vivo assay, which operates with (mechanically wounded) human skin fragments. However, it is unlikely that the putative anti-aging effects of THs can be explained by wound healing inhibition. THs actually promote wound healing, a highly energy-consumptive process, in murine skin in vivo (Kassem et al., 2012; Safer, 2012; Safer et al., 2005) and promotes reepithelialization in experimentally wounded organ-cultured human skin (Meier et al., 2013) ex vivo (Paus lab, unpublished observation), while mice devoid of the TR-alpha and -beta show retarded wound-healing (Contreras-Jurado et al., 2014; Safer et al., 2005) . Moreover, all in situ analyses reported here where purposely performed distant from the periphery of the organ-cultured skin fragments, thus lowering the risk to confound aging-related phenomena with superimposed wound M A N U S C R I P T
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9 healing processes (for detailed discussion of wound healing-related skin responses as a potential confounding element in the current study, see Supplementary Text S1).
In summary, our study identifies T 3 and T 4 as endocrine stimulators of mitochondrial activity and possible biogenesis in normal human skin and raises the intriguing prospect that topical T 4 may be exploited as future therapeutic for skin presenting a decreased bioenergetic status as it is found in various dermatoses and during skin aging (Boulton et al., 2015) . The next challenge is to clarify whether endogenous THs and synthetic TR ligands can actually retard or even reverse mitochondrial function-dependent human skin aging, namely after long-term topical administration.
MATERIALS AND METHODS
Human skin organ culture
Human skin samples (scalp, breast, forearm) were obtained from 7 healthy females (age range: 38-71; mean age: 58) undergoing routine cosmetic plastic surgery after written informed consent and Institutional Research Ethics Committee permission (University of Luebeck), adhering to Helsinki guidelines.
Full-thickness human skin organ culture was performed as previously described (Bodo et al., 2010; Knuever et al., 2012; Lu et al., 2007) . Biopsy punches (4 mm diameter) were generated and cultured at the air-liquid interface. After a 24 hour pre-incubation period, vehicle (William' s E Medium), T 3 (100 pM), T 4 (100 nM) (Sigma-Aldrich; Steinheim, Germany) were added to the media for 24 hours or 6 days. For the 6 days incubation, medium and treatments were changed every second day; TH concentrations were selected based on their documented stimulatory effects on human hair growth (van Beek et al., 2008) and mitochondrial function within human hair follicle epithelium (Vidali et al., 2014) . Human skin largely remains morphologically intact and shows continued proliferative activity under these long-term organ culture conditions (Lu et al., 2007) .
Immunhistochemistry and immunofluorescence
Following cultivation, skin samples were embedded into cryomatrix (THERMO Fisher Scientific; Schwerte, Germany), frozen in liquid nitrogen and stored at -80°C. Sections (6 µm) were prepared for histological analysis. (Langton et al., 2014; Vidali et al., 2014) were used.
The nuclei were demarcated by 4',6-diamidin-2-fenilindolo (DAPI). Omission of the first antibody and absence of IR in skin compartments known to be negative for tested antigens served as negative controls, while confirmation of the skin IR patterns expected from the literature served as positive control.
Quantitative immunohistomorphometry
Images were obtained with a digital microscope (Keyence, Neu-Isenburg, Germany). Quantitative immunohistomorphometry was performed as described before (Knuever et al., 2012; Poeggeler et al., 2010; Vidali et al., 2014) (Supplementary Text S2).
All mitochondrial parameters investigated in the current study were exclusively evaluated in the epidermis, as it is the metabolically most active constituent of the skin, second only to hair follicle epithelium, whose response to THs we had already reported (van Beek et al., 2008; Vidali et al., 2014) . Also, given that organ-cultured skin represents a traumatized tissue, which prominently exhibits wound healing phenomena such as re-epithelisalisation at the tissue edges (Meier et al., 2013) , all read-out parameters reported here were purposely evaluated in the center of the skin punches, i.e. as far away from the wound edge as possible. Therefore all data were harvested in the least-wounded skin environment.
Complex I and complex II /IV activity assay
Respiratory chain complex I activity was visualized by the nitro blue tetrazolium (NBT) reduction assay in situ by incubating skin sections for 3 hours at 37° C with a solution 0.2% of NBT (Merck;
Darmstadt Germany) in phosphate buffer saline (PBS), a negative control with rotenone 3 µM was 
Transmission electron microscopy (TEM)
TEM was performed as previously described (Vidali et al., 2014 ) (see Supplementary Text S5).
In situ zymography
In situ zymography was performed utilizing DQ TM gelatine (Invitrogen; Paisley, UK) (to detect
MMPs-2/-9) and DQ TM collagen (Invitrogen; Paisley, UK) (to detect MMP-1) (see Supplementary
Text S6).
qRT-PCR
Human scalp skin from a 61 years old female was obtained as for the organ culture (see above). Skin was kept in RNAlater (Qiagen, Hilden, Germany) to preserve tissue and kept at -20°C before RNA was extracted. Total RNA was extracted from 4 mm skin punch biopsies with fat removed, using
Qiagen RNA Mini Kit (Qiagen, Hilden, Germany) following the manufacturer's instructions (see Supplementary Text S7).
ROS and ATP production in cultured human keratinocytes
ROS and ATP production in normal human epidermal keratinocytes (NHEK) were assessed as previously described (Vidali et al., 2014 ) (see supplementary text S8)
Statistical analysis
All data were analyzed using One-way-ANOVA or Student's t-test for unpaired samples by employing GraphPad Prism software (GraphPad Prism, La Jolla, CA, USA) (Vidali et al., 2014) P<0.01. It is normally believed that MMPs activity resides in the dermis; however, there is increasing evidence that MMPs (and LOX/LOXLs) have additional activity in the epidermis (Ågren et al., 2015; Fisher et al., 2009) . It is possible that MMPs are released epidermally and then diffuse to the papillary dermis to act on collagens and elastic fiber components. 
